TPO and thyroid gland carcinoma: Our in vitro data show that anti-TPO aAbs do exhibit some capacities to destroy NPA thyroid tumour cells by ADCC or CDC but in the present state, cannot be considered as suitable for thyroid cancer immunotherapy.